Table I.
Group | ALT (U/l) | TG (mmol/l) | AST (U/l) |
---|---|---|---|
C | 19.92±4.98 | 0.74±0.03 | 59.26±6.23 |
M | 43.59±0.61a | 1.95±0.06a | 65.38±2.24a |
T | 36.66±1.12b | 1.62±0.36b | 52.94±2.92b |
G | 34.56±4.05b | 1.52±0.04b | 47.62±4.56b |
N | 35.42±3.53b | 1.47±0.04b | 49.62±1.22b |
L | 23.38±4.91b | 0.90±0.14b | 37.61±3.37b |
Data are reported as mean ± SD, n=10.
P<0.01 vs. C group
P<0.01 vs. M group. ALT, alanine aminotransferase; TG, triglycerides; AST, aspartate transaminase. C, control group; M, ALD group; T, Golden Bifid treatment group; G, Glutamine treatment group; N, Medilac-S® treatment group; L, Golden Bifido and glutamine treatment group.